new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Five Prime Therapeutics Inc patents

Recent patent applications related to Five Prime Therapeutics Inc. Five Prime Therapeutics Inc is listed as an Agent/Assignee. Note: Five Prime Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Five Prime Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Five Prime Therapeutics Inc-related inventors




Date Five Prime Therapeutics Inc patents (updated weekly) - BOOKMARK this page
03/23/17Antibodies that bind colony stimulating factor 1 receptor (csf1r)
11/24/16Afucosylated anti-fgfr2iiib antibodies
11/10/16Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
11/03/16Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
06/30/16Anti-csf1r antibodies for treating pvns
06/02/16Combination therapy for cancer
04/21/16Methods of treating cancer
04/07/16Compositions and methods of treating disease with fgfr fusion proteins
03/10/16Methods of treating cancer
02/18/16Antibodies that bind colony stimulating factor 1 receptor (csf1r)
01/21/16Fam150a, fam150b, and fam150 antagonists and uses thereof
08/20/15Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
07/23/15Fgfr1 extracellular domain combination therapies
02/19/15Afucosylated anti-fgfr2iiib antibodies
10/30/14Antibodies that bind colony stimulating factor 1 receptor (csf1r)
09/18/14Hair growth methods using fgfr3 extracellular domains
06/19/14Compositions and methods of use for mgd-csf in disease treatment
05/22/14Compositions and methods of treating disease with fgfr fusion proteins
03/27/14Therapeutic antibody target validation and screening in vivo
03/20/14Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
02/27/14Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
12/05/13Compositions and methods of treating disease with fgfr fusion proteins
07/25/13Il-27 antagonists for treating inflammatory diseases
03/14/13Compositions and methods of treating disease with fgfr fusion proteins
03/07/13Hair growth methods using fgfr3 extracellular domins
11/29/12Compositions and methods of treating disease with fgfr fusion proteins
10/11/12Compositions and methods of use for mgd-csf in disease treatment
09/20/12Fgfr1 extracellular domain combination therapies
08/30/12Antibodies that bind colony stimulating factor 1 receptor (csf1r)
07/19/12Therapeutic antibody target validation and screening in vivo
07/19/12Il-27 antagonists for treating inflammatory diseases
05/24/12Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
01/05/12Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same
12/29/11Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
11/24/11Compositions and methods for treating arthritis and/or diseases involving cartilage degeneration
11/17/11Compositions and methods of treating disease with fgfr fusion proteins
11/10/11Antibodies that bind csf1r
01/27/11Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
01/06/11Compositions and methods of use for mgd-csf in disease treatment
12/23/10Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma
08/19/10Compositions and methods for treating diseases, disorders, or conditions characterized by myelin degeneration, myelin deficiency or loss
06/24/10Compositions and methods of treating disease with fgfr fusion proteins
06/03/10Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/10Csf1r extracellular domain fusion molecules and treatments using same
04/08/10Fgfr extracellular domain acidic region muteins
03/11/10Novel stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
01/21/10Lung-expressed polypeptides
11/19/09Human cdna clones comprising polynucleotides encoding polypeptides and methods of their use







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Five Prime Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Five Prime Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';